A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause

NCT03728933 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

23

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision; Not a safety decision

Conditions

Restless Legs Syndrome

Interventions

DRUG: Rotigotine 1 milligram/24 hours
DRUG: Rotigotine 2 milligram/24 hours
DRUG: Placebo

Sponsor

UCB Biopharma SRL